Anticollagenase Therapy for Canine Corneal Ulcers: A Narrative Review of Mechanisms, Efficacy, and Clinical Implementation

Anticollagenase therapy may offer adjunctive benefit in the management of canine corneal ulcers, particularly in cases where proteolytic activity is suspected to contribute to disease progression. However, current evidence remains limited and heterogeneous, and further controlled clinical studies are required before definitive recommendations can be made regarding the selection or prioritization of specific agents.